New York State Common Retirement Fund
OLMA icon

New York State Common Retirement Fund’s Olema Pharmaceuticals OLMA Stock Holding History

New York State Common Retirement Fund’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Sell
18,868
-9,366
-33% -$208K ﹤0.01% 2108
2025
Q4 		$706K Buy
28,234
+19,366
+218% +$345K ﹤0.01% 1832
2025
Q3 		$86.8K Hold
8,868
– – ﹤0.01% 2690
2025
Q2 		$37.8K Hold
8,868
– – ﹤0.01% 3014
2025
Q1 		$33.3K Hold
8,868
– – ﹤0.01% 2890
2024
Q4 		$51.7K Hold
8,868
– – ﹤0.01% 2847
2024
Q3 		$106K Sell
8,868
-8,122
-48% -$104K ﹤0.01% 2559
2024
Q2 		$184K Buy
16,990
+10,036
+144% +$109K ﹤0.01% 2464
2024
Q1 		$78.7K Buy
6,954
+436
+7% +$5.63K ﹤0.01% 2835
2023
Q4 		$91.4K Sell
6,518
-72
-1% -$967 ﹤0.01% 2780
2023
Q3 		$81.4K Sell
6,590
-5,510
-46% -$56.2K ﹤0.01% 2822
2023
Q2 		$109K Buy
+12,100
New +$73.1K ﹤0.01% 2757
2022
Q3 		– Sell
-207
Closed -$1K – 3399
2022
Q2 		$1K Sell
207
-17,600
-99% -$55.8K ﹤0.01% 3384
2022
Q1 		$76K Hold
17,807
– – ﹤0.01% 3078
2021
Q4 		$167K Buy
17,807
+4,983
+39% +$103K ﹤0.01% 2934
2021
Q3 		$353K Buy
12,824
+1,326
+12% +$35.8K ﹤0.01% 2656
2021
Q2 		$322K Buy
11,498
+5,498
+92% +$156K ﹤0.01% 2812
2021
Q1 		$199K Buy
+6,000
New +$257K ﹤0.01% 2833

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

New York State Common Retirement Fund's OLMA Position: Q1 2026 in Review

New York State Common Retirement Fund reduced its Olema Pharmaceuticals (OLMA) stake by 33% in Q1 2026, selling an estimated $208K and leaving 18,868 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

New York State Common Retirement Fund first reported a position in OLMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $706K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • New York State Common Retirement Fund held 18,868 shares of Olema Pharmaceuticals worth $281K as of Q1 2026.
  • New York State Common Retirement Fund sold 9,366 Olema Pharmaceuticals shares in Q1 2026, an estimated $208K.
  • Olema Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2108 holding.
  • New York State Common Retirement Fund first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Olema Pharmaceuticals position peaked at $706K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.